Position in PCVX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$93,777,757
+$13,717,402 QoQ
Shares Held
1,613,242
+17.1% QoQ
Ownership
1.08%
of shares outstanding
% of Portfolio
0.85%
of 13F equity value
Holder Rank
#19
of 330 holders
Holding Since
Mar 2024
10 quarters on record
Common Shares in PCVX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MAVERICK CAPITAL LTD holds $942,556,118 across 15 Biotechnology names. PCVX ranks #6 (9.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
2,150,762 | $229,314,244 | |
| 2 | NAMS |
NewAmsterdam Pharma Co N.V.
|
3,267,802 | $110,745,809 | |
| 3 | TECH |
BIO-TECHNE Corp
|
1,535,610 | $108,490,846 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
2,829,024 | $100,119,159 | |
| 5 | MANE |
Veradermics, Inc
|
789,980 | $97,120,141 | |
| 6 | PCVX |
Vaxcyte, Inc.
This page
|
1,613,242 | $93,777,757 | |
| 7 | BLTE |
Belite Bio, Inc
|
396,311 | $61,025,949 | |
| 8 | WVE |
Wave Life Sciences, Inc.
|
10,278,115 | $59,715,848 |
All Filings in PCVX
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $93,777,757 | 1,613,242 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $80,060,355 | 1,377,738 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $62,484,495 | 1,354,237 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $46,450,203 | 1,289,567 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $42,607,768 | 1,310,605 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $45,617,591 | 1,208,093 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $98,387,370 | 1,201,898 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $111,555,973 | 976,249 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $51,943,933 | 687,908 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $24,258,998 | 355,131 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||